ATLAS / Macro Radar / Reporting / APGE

Apogee Therapeutics, Inc. (APGE) reporting calendar

Apogee Therapeutics, Inc. files periodic reports with the SEC as APGE on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
1 Aug 2026 – 21 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open APGE market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-215698
10-K31 Dec 20252 Mar 202661 days0001974640-26-000002
10-Q30 Sep 202510 Nov 202541 days0001193125-25-273260
10-Q30 Jun 202511 Aug 202542 days0000950170-25-106234
10-Q31 Mar 202512 May 202542 days0000950170-25-068513
10-K31 Dec 20243 Mar 202562 days0000950170-25-030385
10-Q30 Sep 202412 Nov 202443 days0000950170-24-124559
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095053
10-Q31 Mar 202413 May 202443 days0001558370-24-007861
10-K31 Dec 20235 Mar 202465 days0001558370-24-002406
10-Q30 Sep 202313 Nov 202344 days0001558370-23-018692
10-Q30 Jun 202328 Aug 202359 days0001558370-23-015278

Source: SEC EDGAR company submissions for CIK 0001974640. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.